2026 NPPES data Internal Medicine Physician NPI 1831658061 APRN
Verify on CMS →

MELISSA BRESNAHAN, APRN

Internal Medicine Physician in MIDDLEBORO, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 471 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$139.36
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MELISSA BRESNAHAN, APRN filed 2,891 Medicare Part D claims in 2023 as a Internal Medicine Physician in MIDDLEBORO, Massachusetts, prescribing 87% generic.

3K
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MELISSA BRESNAHAN, APRN's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,891 Top 12% higher than 88% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MELISSA BRESNAHAN, APRN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MELISSA BRESNAHAN, APRN?

Quality data not reported

NPI registry status

Active

Issued 03/18/2019

NPI 1831658061

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

2,891 6% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in Massachusetts

How Internal Medicine Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Internal Medicine Physician share within Massachusetts

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MELISSA BRESNAHAN, APRN appears in the CMS NPPES registry as a Internal Medicine Physician provider holding APRN credentials at 8 COMMERCE BLVD, MIDDLEBORO, MA, 02346, with a listed phone of (774) 260-9300. NPI 1831658061 was issued on 03/18/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRESNAHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,891 prescription claims written by this provider, covering 471 Medicare beneficiaries and totaling roughly $269K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 2.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8 COMMERCE BLVD
MIDDLEBORO, MA 02346

Provider Details

NPI 1831658061
Specialty Internal Medicine Physician
Credentials APRN
Gender Female
NPI Issued 03/18/2019

Hospital and facility affiliations

Facilities where MELISSA BRESNAHAN, APRN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEDICAL CARE OF BOSTON MANAGEMENT CORPORATION
SHARON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MELISSA BRESNAHAN, APRN. Source: openpaymentsdata.cms.gov.

Total received

$139

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MELISSA BRESNAHAN, APRN. To verify MELISSA BRESNAHAN, APRN's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MELISSA BRESNAHAN, APRN — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 2,891 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,891
Total Claims
$269K
Total Drug Cost
471
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,310
Total Day Supply
148,957
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$214K
Generic Drug Cost
$54K
Opioid Claims
83 (2.9% rate)
Antibiotic Claims
133

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
1.25
Gender Split
76% female / 24% male
Age Distribution
<65: 94, 65-74: 208, 75-84: 130, 85+: 39

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MELISSA BRESNAHAN, APRN prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
118
Levothyroxine Sodium
112
Atorvastatin Calcium
109
Losartan Potassium
85
Sertraline Hcl
81
Albuterol Sulfate Hfa
Albuterol Sulfate
72
Amlodipine Besylate
72
Lorazepam
70
Lisinopril
68
Omeprazole
56

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How MELISSA BRESNAHAN, APRN fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

MELISSA BRESNAHAN, APRN's 2,891 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BRESNAHAN.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MELISSA BRESNAHAN, APRN's specialty?
MELISSA BRESNAHAN, APRN specializes in Internal Medicine Physician and practices in MIDDLEBORO, Massachusetts. Credentials: APRN.
How much does MELISSA BRESNAHAN, APRN prescribe under Medicare Part D?
In 2023, MELISSA BRESNAHAN, APRN wrote 2,891 Medicare Part D claims totaling $269K in drug costs for 471 beneficiaries.
Where is MELISSA BRESNAHAN, APRN located?
MELISSA BRESNAHAN, APRN is located at 8 COMMERCE BLVD, MIDDLEBORO, MA, 02346. Phone: (774) 260-9300.
What is MELISSA BRESNAHAN, APRN's NPI number?
MELISSA BRESNAHAN, APRN's National Provider Identifier (NPI) is 1831658061, issued on 03/18/2019.
Does MELISSA BRESNAHAN, APRN prescribe more brand-name or generic drugs?
MELISSA BRESNAHAN, APRN's prescribing is 13% brand-name and 87% generic drugs by claim count, with $214K in brand drug costs.
Does MELISSA BRESNAHAN, APRN prescribe opioids?
Yes, MELISSA BRESNAHAN, APRN had 83 opioid claims in 2023 with an opioid prescribing rate of 2.9%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does MELISSA BRESNAHAN, APRN prescribe most often?
Based on 2023 Medicare Part D data, MELISSA BRESNAHAN, APRN's most frequently prescribed drugs include Gabapentin, Levothyroxine Sodium, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MELISSA BRESNAHAN, APRN accept Medicare?
MELISSA BRESNAHAN, APRN appears in CMS Medicare data with 2,891 Part D claims and 471 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MELISSA BRESNAHAN, APRN's credentials?
MELISSA BRESNAHAN, APRN's NPI is 1831658061 with credentials APRN. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology